Core Protocol
90 capsules · 30 daily servings
One-time purchase
Adding to your bag…
Subtotal—
Your total will appear once your bag is updated.
Your bag is empty.
Start with thirty days of Core Protocol.
The Energist exists to redefine what energy means for modern work.
In a culture built on overstimulation - caffeine, sugar, urgency - we take a different approach. One rooted in cellular energy, cognitive clarity, and composure under pressure.
Every Energist formulation is built around clinically researched ingredients, selected for their ability to support sustained mental performance without hijacking the nervous system. No artificial urgency. No spikes or crashes. Just intelligent energy, designed for demanding days and long careers.
We believe performance should be sustainable - not borrowed from tomorrow.
Thinking clearly takes energy. Core Protocol brings together three caffeine-free ingredients, informed by human research into cellular energy, mental fatigue and stress.
A precursor your body uses to make NAD+, a coenzyme involved in cellular energy metabolism.
Mean increase from baseline with 300 mg NR daily in overweight, otherwise healthy adults.
Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults.
140 adults across the study · 8 weeks · Highlighted result: 300 mg/day, day 14. DOI: 10.1038/s41598-019-46120-z.
NR raised blood NAD+ in adults with mild cognitive impairment.
A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment.
20 participants · 10 weeks · Dose escalation to 1,000 mg/day. Cognition remained unchanged. DOI: 10.1007/s11357-023-00999-9.
NADPARK reported a variable increase in brain NAD after NR supplementation in people with Parkinson’s disease.
The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease.
30 participants · 30 days · 1,000 mg/day. DOI: 10.1016/j.cmet.2022.02.001.
Selected for its role in energy metabolism and research into mental fatigue.
The ALCAR group reported a significant improvement during 24 weeks in adults with chronic fatigue syndrome.
Exploratory open label, randomized study of acetyl- and propionylcarnitine in chronic fatigue syndrome.
90 participants across three groups · ALCAR, 2,000 mg/day · Mental fatigue p = 0.015. DOI: 10.1097/01.psy.0000116249.60477.e9.
ALCAR improved MoCA-K scores versus placebo in patients with dementia associated with cerebrovascular disease.
A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial for Efficacy of Acetyl-L-carnitine in Patients with Dementia Associated with Cerebrovascular Disease.
56 participants · 28 weeks · 1,500 mg/day. DOI: 10.12779/dnd.2018.17.1.1.
A combination of ALCAR, vinpocetine and huperzine A improved a composite memory score in a 28-day placebo-controlled study.
The Effects on the Cognitive Function of Healthy Volunteers of a Combination of Acetyl-L-Carnitine, Vinpocetine and Huperzine A Administered Over 28 Days.
Combination: 1,500 mg ALCAR, 15 mg vinpocetine and 150 µg huperzine A daily. DOI: 10.23937/2378-3001/1410089.
An adaptogen studied for fatigue and focus under stress.
SHR-5 improved selected attention measures and burnout-related fatigue, with a lower waking cortisol response after 28 days.
A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue.
60 adults · 576 mg/day. Mean attention-test omissions: 6.29 to 2.41 with SHR-5; 4.70 to 4.29 with placebo. Cortisol analysis: 46 participants.
SHR-5 names the specific standardised root extract. The HPA (hypothalamic-pituitary-adrenal) system regulates the stress response, including cortisol release. DOI: 10.1055/s-0028-1088346.
A trial in 56 healthy physicians reported improved combined mental performance during the first two-week treatment period.
Rhodiola rosea in stress induced fatigue: a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty.
PMID: 11081987.
A clinical overview discussing Rhodiola’s use in stress-induced conditions.
The Clinical Efficacy of Rhodiola rosea L. in Managing Stress-Induced Conditions.
37(4):233–235. DOI: 10.1097/HNP.0000000000000597.
Selected ingredient research. Study populations, preparations and doses are identified with each reference.
